Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Capstone Therapeutics Corp. (CAPS : NSDQ)

• Company Description    Capstone Holding Corp. primary business activities presently include the operations of TotalStone LLC, a construction materials company. Capstone Holding Corp. is headquartered in Alsip, Illinois. Number of Employees: 38

• Price / Volume Information    Yesterday's Closing Price: $0.73 Daily Weekly Monthly 20 Day Moving Average: 183,400 shares Shares Outstanding: 8.31 (millions) Market Capitalization: $6.05 (millions) Beta: -1.21 52 Week High: $4.18 52 Week Low: $0.64 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.38% -15.24% 12 Week -40.34% -41.30% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5141 W. 122nd Street - Alsip,IL 60803 USA ph: 708-371-0660 fax: 602-286-5300 investors@capstoneholdingcorp.com http://www.capstonethx.com

• General Corporate Information    Officers Matthew E.Lipman - Chief Executive Officer Michael Toporek - Chairman Edward Schultz - Chief Financial Officer John M.Holliman - Director Gordon Strout - Director Peer Information Capstone Therapeutics Corp. (CSRLY) Capstone Therapeutics Corp. (ARRD) Capstone Therapeutics Corp. (CGMCQ) Capstone Therapeutics Corp. (CMCJY) Capstone Therapeutics Corp. (OMRP) Capstone Therapeutics Corp. (ABLT) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: BLDG&CONST-MISC Sector: Construction CUSIP: 14068E208 SIC: 5030 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/17/26 Share - Related Items Shares Outstanding: 8.31 Most Recent Split Date: 9.00 (0.00:1) Beta: -1.21 Market Capitalization: $6.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/17/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.21 Price/Cash Flow: - Price / Sales: 0.14 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -169.23% Sales Growth vs. Year Ago Period: 10.85% vs. Previous Quarter: 6.24% ROE 12/31/25 - - 09/30/25 - -29.50 06/30/25 - -27.90 ROA 12/31/25 - - 09/30/25 - -10.60 06/30/25 - -9.25 Current Ratio 12/31/25 - - 09/30/25 - 0.95 06/30/25 - 0.97 Quick Ratio 12/31/25 - - 09/30/25 - 0.35 06/30/25 - 0.41 Operating Margin 12/31/25 - - 09/30/25 - -12.43 06/30/25 - -8.07 Net Margin 12/31/25 - - 09/30/25 - -12.40 06/30/25 - -8.06 Pre-Tax Margin 12/31/25 - - 09/30/25 - -11.46 06/30/25 - -7.08 Book Value 12/31/25 - - 09/30/25 - 3.45 06/30/25 - 4.85 Inventory Turnover 12/31/25 - - 09/30/25 - 3.39 06/30/25 - 4.67 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.29 06/30/25 - 0.22 Debt-to-Capital 12/31/25 - - 09/30/25 - 21.02 06/30/25 - 18.15

Powered by Zacks Investment Research ©